Telix Pharmaceuticals Ltd (TLX.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2018 | 09-2018 | 06-2018 | 03-2018 | 12-2017 | |
| Cash Flows From Operating Activities | |||||
| Operating Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| Net Acquisitions | -2,267 | N/A | N/A | N/A | N/A |
| Purchase Sale Intangibles | -58 | -294 | N/A | N/A | N/A |
| Other Investing Activity | -261 | 0 | 4 | 0 | -653 |
| Investing Cash Flow | $-2,587 | $-294 | $4 | $N/A | $-653 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | N/A | N/A | 39,039 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -2,494 |
| Financing Cash Flow | $N/A | $N/A | $N/A | $N/A | $36,545 |
| Exchange Rate Effect | 387 | 386 | N/A | N/A | N/A |
| Beginning Cash Position | 26,269 | 30,366 | 34,219 | 37,368 | 3,403 |
| End Cash Position | 18,081 | 26,937 | 30,883 | 35,748 | 37,981 |
| Net Cash Flow | $-8,576 | $-3,815 | $-3,337 | $-1,620 | $34,578 |
| Free Cash Flow | |||||
| Capital Expenditure | -58 | -294 | N/A | N/A | N/A |
| Free Cash Flow | -58 | -294 | 0 | 0 | 0 |